Akums Drugs and Pharmaceuticals Limited — Updates, 14-05-2026: General Updates

Akums approved Q4 & FY26 financial results. Consolidated net profit reached ₹256.40 Cr on ₹4,359.02 Cr revenue for the year. The company proposed a ₹3.00 dividend per equity share. Additionally, ₹12.60 Cr in excess IPO expenses was reallocated for acquisitions and general corporate purposes.